Ro Sandoval, research technician in the Moron-Concepcion Lab, was recently recognized by the Society for the Advancement of Chicanos/Hispanics and Native Americans in Science (SACNAS).
Research Student Recognized at SACNAS Annual Meeting
Category: Research
Alex Evers, MD, named Interim Director of the Center for Clinical Pharmacology (CCP)
Dr. Evers will serve as the Interim Director of the Center for Clinical Pharmacology (CCP) as leadership looks to recruit a dynamic and visionary Center Director.
Jose Moron-Concepcion, PhD, to present opioid research findings at IPRCC meeting
Dr. Moron-Concepcion’s presentation will focus on how persistent pain alters the rewarding and motivational properties of opioids and will highlight the work of the research being conducted in the department.
Bradley Fritz, MD, MCSI, receives FAER training grant
Dr. Fritz’s project focuses on how machine learning can be used to determine which patients are at high risk for complications after surgery.
Could the MMR Vaccine Protect Against COVID-19? Global Trial Enrolls Healthcare Workers to Find Out (Links to an external site)
Investigators discuss their hope for the MMR vaccine in the fight against COVID-19, as well as the importance for everyone to get their scheduled vaccinations.
Global trial to test whether MMR vaccine protects front-line health-care workers against COVID-19 (Links to an external site)
Vaccine may strengthen immune response to viral infections; trial to enroll up to 30,000 health-care workers .
Three junior PIs secure major grant awards from NIH
Meaghan Creed, PhD, Wayland Cheng, MD, PhD, and Jordan McCall, PhD, recently received their first R01 or R35 research grants from the National Institutes of Health.
Gereau honored for mentorship and training in neuroscience research (Links to an external site)
Robert W. Gereau IV, PhD, has received the Landis Award for Outstanding Mentorship from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH).
Boosting immune system a potential treatment strategy for COVID-19 (Links to an external site)
New research suggests that the immune systems of COVID-19 patients can’t do enough to protect them from the virus. Researchers are proposing that boosting the immune system could be a potential treatment strategy.
Simon Haroutounian, PhD, appointed Chief of the Division of Clinical and Translational Research (DoCTR)
Dr. Haroutounian also serves as Associate Professor of Anesthesiology and an Adjunct Assistant Professor of Pharmacy Practice at the St. Louis College of Pharmacy.